CXCL5 and familial pancreatic carcinoma: For CXCL5, previous reports are more equivocal, showing up-regulation correlated to poor survival in colorectal and pancreatic cancer [45], [46], whereas another study showed correlation with under-expression of CXCL5 and poor survival for colorectal cancer [47].